ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,950Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 1802

$927K Total Retail Price of All Prescriptions

Rank: 8 out of 1802

319 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 319 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 319 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 16,318 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
FUROSEMIDE 766 722 1 5
LEVOTHYROXINE SODIUM 715 673 2 2
WARFARIN SODIUM 532 487 3 7
LISINOPRIL 490 448 4 3
TRAMADOL HCL 487 462 5 22
CITALOPRAM HBR 484 450 6 17
POTASSIUM CHLORIDE 452 416 7 15
NAMENDA 448 448 8 34
RANITIDINE HCL 447 437 9 30
METOPROLOL TARTRATE 426 414 10 9
AMLODIPINE BESYLATE 400 381 11 6
SERTRALINE HCL 350 300 12 20
SIMVASTATIN 299 263 13 1
METOPROLOL SUCCINATE 295 288 14 13
FLUOXETINE HCL 288 247 15 35
OMEPRAZOLE 274 261 16 4
RISPERIDONE 240 229 17 64
MIRTAZAPINE 228 215 18 38
DONEPEZIL HCL 226 226 19 26
CARBIDOPA-LEVODOPA 212 207 20 70
ADVAIR DISKUS 211 198 21 32
HYDROCHLOROTHIAZIDE 205 193 22 8
DIGOXIN 202 202 23 45
ISOSORBIDE MONONITRATE ER 200 200 24 66
VENLAFAXINE HCL ER 198 198 25 73
AMITRIPTYLINE HCL 185 185 R 26 80
CYMBALTA 185 175 26 75
METFORMIN HCL 183 159 28 11
POLYETHYLENE GLYCOL 3350 172 144 29 29
QUETIAPINE FUMARATE 169 137 30 54
GABAPENTIN 164 115 31 16
OLANZAPINE 152 120 32 112
SPIRIVA 151 151 33 72
DIVALPROEX SODIUM 142 136 34 74
ATENOLOL 140 139 35 12
TAMSULOSIN HCL 135 123 36 28
ACETIC ACID 128 68 10 37 258
ALBUTEROL SULFATE 116 111 38 136
PREDNISONE 115 111 39 33
IPRATROPIUM-ALBUTEROL 111 111 40 97
CARVEDILOL 111 111 40 36
SPIRONOLACTONE 106 106 42 53
ALLOPURINOL 100 100 43 24
GLIPIZIDE XL 97 86 44 98
TRAZODONE HCL 93 80 45 39
LANTUS 93 65 45 47
FLUTICASONE PROPIONATE 93 89 45 37
BACLOFEN 91 55 48 106
LOSARTAN POTASSIUM 90 90 49 18
ENALAPRIL MALEATE 89 89 50 40
SEROQUEL 89 73 50 128
GLIMEPIRIDE 88 68 52 42
MORPHINE SULFATE 85 76 S2 53 174
FINASTERIDE 84 84 54 88
LAMOTRIGINE 83 41 55 114
FENTANYL 82 82 S2 56 43
RESTASIS 82 82 56 293
HYDRALAZINE HCL 80 80 58 119
FENOFIBRATE 79 54 59 56
KETOCONAZOLE 75 62 60 193
RISPERDAL CONSTA 75 75 60 295
PHENYTOIN 74 74 62 296
GLIPIZIDE 73 73 63 51
NOVOLOG 72 64 64 100
ATORVASTATIN CALCIUM 71 69 65 14
LYRICA 70 53 66 107
JANTOVEN 70 70 66 123
LIDODERM 70 69 66 92
METOCLOPRAMIDE HCL 69 60 69 134
PLAVIX 69 69 69 81
NOVOLIN N 69 69 69 234
ALENDRONATE SODIUM 68 60 72 21
FOSINOPRIL SODIUM 64 51 73 149
LEVETIRACETAM 64 17 73 105
CLOPIDOGREL 64 64 73 48
MOMETASONE FUROATE 64 52 73 310
TRIAMTERENE-HCTZ 59 59 77 49
TIZANIDINE HCL 59 21 77 160
DETROL LA 56 44 79 202
TRAVATAN Z 55 55 80 188
OXYBUTYNIN CHLORIDE ER 52 41 81 99
DOXAZOSIN MESYLATE 51 51 82 62
CIPROFLOXACIN HCL 51 43 82 109
DIOVAN 50 50 84 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.